Pfizer secures $10 billion Metsera deal after Novo Nordisk withdraws
Pfizer’s $10 billion acquisition of Metsera marks a major victory for the U.S. pharmaceutical giant, strengthening its position in the
Read More
Factual Version of a Story
healthcare innovation
Novartis Strengthens Rare Disease Focus with $12 Billion Avidity Biosciences Deal
In a landmark move to advance treatments for rare muscle disorders, Novartis takes a major step toward expanding its innovation
Read More
Humana Reaffirms Commitment to Quality Care and Service Excellence Despite Medicare Ruling
Following a U.S. court’s decision upholding the 2025 Medicare Advantage ratings, Humana renews its focus on improving patient care, service
Read More
Bill Gates and PAHO Explore Affordable Access to Weight-Loss Drugs for Developing Nations
London – In a move that could reshape global health access, philanthropist Bill Gates and the Pan American Health Organization
Read More
Johnson & Johnson Eyes Major Leap in Biotech: Talks Underway to Acquire Protagonist Therapeutics in Billion-Dollar Move
In a bold bid to expand its cutting-edge drug pipeline, Johnson & Johnson is reportedly in advanced talks to acquire
Read More
Novo Nordisk Makes Bold $5.2 Billion Move with Akero Buyout to Accelerate Liver Disease Breakthroughs
In a landmark deal marking a new era under CEO Mike Doustdar, Novo Nordisk acquires Akero Therapeutics for up to
Read More
Saudi Arabia to Unveil Major Biotech and Pharmaceutical Partnerships at Global Health Exhibition 2025
Riyadh – Saudi Arabia’s healthcare sector is poised for another wave of growth and innovation, as new biotechnology and pharmaceutical
Read More
Philips in talks with US over probes of medical technology imports
“At this stage, details are limited, and a range of potential outcomes remain under discussion,” said Philips in a statement,
Read More